MX174336B - Composiciones que contienen l-tartrato de l-carnitina y procedimiento para su preparacion - Google Patents
Composiciones que contienen l-tartrato de l-carnitina y procedimiento para su preparacionInfo
- Publication number
- MX174336B MX174336B MX023891A MX2389190A MX174336B MX 174336 B MX174336 B MX 174336B MX 023891 A MX023891 A MX 023891A MX 2389190 A MX2389190 A MX 2389190A MX 174336 B MX174336 B MX 174336B
- Authority
- MX
- Mexico
- Prior art keywords
- carnitine
- tartrate
- preparation
- procedure
- compositions containing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/03—Organic compounds
- A23L29/045—Organic compounds containing nitrogen as heteroatom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Food Science & Technology (AREA)
- Diabetes (AREA)
- Organic Chemistry (AREA)
- Obesity (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Polymers & Plastics (AREA)
- Hematology (AREA)
- Zoology (AREA)
- Physiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
La presente invención se refiere a composición oral, sólida, no higroscópica, estable en almacenamiento, caracterizada porque comprende por lo menos una tableta compuesta de sal de L-carnitina con ácido L-tartárico en una proporción molar de 2:1, polvo compuesto de la sal de L-carnitina con ácido L-tartático en una relación molar de 2:1, o por lo menos una cápsula que contiene la sal de L-carnitina con ácido L-tartárico en una relación molar de 2:1.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH463389 | 1989-12-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
MX174336B true MX174336B (es) | 1994-05-09 |
Family
ID=4279783
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX023891A MX174336B (es) | 1989-12-22 | 1990-12-21 | Composiciones que contienen l-tartrato de l-carnitina y procedimiento para su preparacion |
Country Status (11)
Country | Link |
---|---|
US (1) | US5073376A (es) |
EP (1) | EP0434088B1 (es) |
JP (1) | JP2546068B2 (es) |
AT (1) | ATE89721T1 (es) |
CA (1) | CA2030838C (es) |
DE (1) | DE59001556D1 (es) |
FI (1) | FI906245A (es) |
HU (1) | HU210933B (es) |
IL (1) | IL96699A (es) |
MX (1) | MX174336B (es) |
PT (1) | PT96330B (es) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030170290A1 (en) * | 1993-06-16 | 2003-09-11 | Shug Austin L. | Delayed release carnitine |
US5707971A (en) * | 1995-06-07 | 1998-01-13 | Life Resuscitation Technologies, Inc. | Modulation of glycolytic ATP production |
IT1289974B1 (it) * | 1997-02-25 | 1998-10-19 | Aldo Fassi | Procedimento per la produzione di sali stabili e non igroscopici di l(-)carnitina e di alcanoli l(-)-carnitine |
EP0914315B1 (en) * | 1996-05-31 | 2001-04-11 | Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. | Stable, non-hygroscopic salts of l(-)carnitine and alkanoyl l(-)carnitines, a process for their preparation and solid, orally administrable compositions containing such salts |
IT1291126B1 (it) * | 1997-04-01 | 1998-12-29 | Sigma Tau Ind Farmaceuti | Composizioni solide atte alla somministrazione orale comprendenti sali non igroscopici della l-carnitina e delle alcanoil l-carnitine |
IT1291133B1 (it) * | 1997-04-07 | 1998-12-29 | Sigma Tau Ind Farmaceuti | Composizioni solide atte alla somministrazione orale comprendenti l-carnitina e alcanoil l-carnitine magnesio tartrato |
IT1291134B1 (it) * | 1997-04-08 | 1998-12-29 | Sigma Tau Ind Farmaceuti | Composizioni solide atte alla somministrazione orale comprendenti una alcanoil l-carnitina magnesio citrato |
IT1291143B1 (it) * | 1997-04-18 | 1998-12-29 | Sigma Tau Ind Farmaceuti | Composizioni solide atte alla somministrazione orale comprendenti l-carnitina colina tartrato o una alcanoil l-carnitina colina |
IT1290600B1 (it) * | 1997-04-30 | 1998-12-10 | Sigma Tau Ind Farmaceuti | Composizioni solide atte alla somministrazione orale comprendenti l-carnitina e alcanoil l-carnitine magnesio fumarato |
IT1299544B1 (it) * | 1998-07-03 | 2000-03-16 | Sigma Tau Ind Farmaceuti | Composizioni solide atte alla somministrazione orale comprendenti sali non igroscopici della l-carnitina e delle alcanoil l-carnitine |
IT1312018B1 (it) * | 1999-03-19 | 2002-04-04 | Fassi Aldo | Procedimento migliorato per la produzione di sali non igroscopicidella l(-)-carnitina. |
IT1305308B1 (it) * | 1999-03-26 | 2001-05-04 | Biosint S P A | Granulato ad alto contenuto di l-carnitina o alcanoil-l-carnitina,particolarmente adatto alla produzione di compresse per compressione |
ITRM20010030A1 (it) * | 2001-01-23 | 2002-07-23 | Aldo Fassi | Sali di carnitine utili come integratori dietetici/nutrizionali o come farmaci, composizioni che li contengono e procedimenti per la loro pr |
DE10113446A1 (de) | 2001-03-19 | 2002-09-26 | Schwarzkopf Gmbh Hans | Haarbehandlungsmittel mit Betainen |
ITRM20010445A1 (it) * | 2001-07-25 | 2003-01-27 | Sigma Tau Healthscience Spa | Alfa-chetoglutarati di principi attivi e composizioni che li contengono. |
US20040001817A1 (en) * | 2002-05-14 | 2004-01-01 | Giampapa Vincent C. | Anti-aging nutritional supplement |
DE10350140A1 (de) * | 2003-03-28 | 2004-10-14 | Martin Schymura | Fruchtgummizusammensetzung |
JP2006111550A (ja) * | 2004-10-13 | 2006-04-27 | Nisshin Pharma Inc | カルニチン含有製品 |
CN101912045B (zh) * | 2005-07-05 | 2013-07-31 | 隆萨股份公司 | 生产干肉碱粉末或颗粒的喷雾干燥法 |
DE102005062360A1 (de) | 2005-12-23 | 2007-06-28 | Henkel Kgaa | Haarfärbeverfahren |
JP5069416B2 (ja) * | 2006-03-15 | 2012-11-07 | サントリーホールディングス株式会社 | 吸湿性の改善された飲食品用組成物 |
CN101209975B (zh) | 2006-12-29 | 2010-12-01 | 沈阳科硕营养科技有限公司 | 左旋肉碱富马酸钙及其制备方法与用途 |
GR1006148B (el) * | 2007-12-07 | 2008-11-10 | Uni-Pharma Κλεων Τσετης, Φαρμακευτικα Εργαστηρια Αβεε | Αναβραζοντα δισκια και αναβραζοντα κοκκια που περιεχουν τρυγικη καρνιτινη |
JP5367328B2 (ja) * | 2008-09-01 | 2013-12-11 | 株式会社ファンケル | カルニチン含有製剤 |
JP2011068563A (ja) * | 2008-09-09 | 2011-04-07 | Mitsubishi Rayon Co Ltd | カルニチンフマル酸塩及びその製造方法 |
EP2335495A1 (en) | 2009-12-11 | 2011-06-22 | Lonza Ltd. | Carnitine granulate and methods for its production |
PL217815B1 (pl) * | 2009-12-14 | 2014-08-29 | Olimp Lab Spółka Z Ograniczoną Odpowiedzialnością | Napój izotoniczny z chelatami |
EP2425834A1 (en) | 2010-09-06 | 2012-03-07 | Lonza Ltd. | Process for the production of l-carnitine tartrate |
KR20140019827A (ko) * | 2011-04-05 | 2014-02-17 | 론자 아게 (론자 엘티디.) | 피로를 감소 또는 예방하고 인지 기능을 개선시키기 위한 l-카르니틴, 그의 염 및 유도체의 용도 |
CN106748845B (zh) * | 2016-12-23 | 2018-11-20 | 东北制药集团股份有限公司 | 一种左旋肉碱盐微粉的制备方法 |
KR101978364B1 (ko) | 2017-06-15 | 2019-05-14 | 크리스탈지노믹스(주) | 알킬카바모일 나프탈렌일옥시 옥테노일 하이드록시아마이드 또는 그 유도체의 약학적으로 허용 가능한 염 및 그 제조방법 |
CN109096129B (zh) * | 2018-09-30 | 2021-04-27 | 东北制药集团股份有限公司 | 一种左旋肉碱酒石酸盐的制备方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DD93347A (es) * | ||||
US3274055A (en) * | 1962-12-10 | 1966-09-20 | Synergistics Inc | Acid addition salts of morpholine ethanol |
US3810994A (en) * | 1972-06-01 | 1974-05-14 | Ethyl Corp | Method and composition for treating obesity |
DE2903558C2 (de) * | 1978-02-03 | 1994-09-01 | Sigma Tau Ind Farmaceuti | Verwendung von L-Carnitin |
GB2058566A (en) * | 1979-09-21 | 1981-04-15 | Sigma Tau Ind Farmaceuti | Pharmaceutical composition comprising L-carnitine |
JPS57126420A (en) * | 1981-01-26 | 1982-08-06 | Eiji Murakami | Drug for digestive organ |
DE3463261D1 (en) * | 1983-12-28 | 1987-05-27 | Sigma Tau Ind Farmaceuti | Salts of l-carnitine and alkanoyl l-carnitines and process for preparing same |
US4537772A (en) * | 1984-05-02 | 1985-08-27 | Merck & Co., Inc. | Enhancing absorption of drugs from gastrointestinal tract using acylcarnitines |
JPS649287A (en) * | 1988-04-08 | 1989-01-12 | Seiko Epson Corp | Dynamic drive liquid crystal display |
-
1990
- 1990-03-27 US US07/499,629 patent/US5073376A/en not_active Expired - Lifetime
- 1990-11-26 CA CA002030838A patent/CA2030838C/en not_active Expired - Lifetime
- 1990-12-17 IL IL9669990A patent/IL96699A/en not_active IP Right Cessation
- 1990-12-17 JP JP2402808A patent/JP2546068B2/ja not_active Expired - Fee Related
- 1990-12-18 FI FI906245A patent/FI906245A/fi not_active Application Discontinuation
- 1990-12-21 DE DE9090125138T patent/DE59001556D1/de not_active Revoked
- 1990-12-21 AT AT90125138T patent/ATE89721T1/de not_active IP Right Cessation
- 1990-12-21 PT PT96330A patent/PT96330B/pt not_active IP Right Cessation
- 1990-12-21 MX MX023891A patent/MX174336B/es unknown
- 1990-12-21 HU HU908404A patent/HU210933B/hu unknown
- 1990-12-21 EP EP90125138A patent/EP0434088B1/de not_active Revoked
Also Published As
Publication number | Publication date |
---|---|
HU210933B (en) | 1995-09-28 |
HU908404D0 (en) | 1991-07-29 |
JPH04128223A (ja) | 1992-04-28 |
PT96330B (pt) | 1998-06-30 |
CA2030838A1 (en) | 1991-06-23 |
IL96699A0 (en) | 1991-09-16 |
HUT59306A (en) | 1992-05-28 |
CA2030838C (en) | 2000-05-09 |
FI906245A0 (fi) | 1990-12-18 |
PT96330A (pt) | 1991-09-30 |
US5073376A (en) | 1991-12-17 |
EP0434088B1 (de) | 1993-05-26 |
JP2546068B2 (ja) | 1996-10-23 |
DE59001556D1 (de) | 1993-07-01 |
ATE89721T1 (de) | 1993-06-15 |
FI906245A (fi) | 1991-06-23 |
IL96699A (en) | 1995-12-31 |
EP0434088A1 (de) | 1991-06-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX174336B (es) | Composiciones que contienen l-tartrato de l-carnitina y procedimiento para su preparacion | |
MX9204354A (es) | Compuestos heterociclicos de 5 miembros, procedimiento para prepararlos y composiciones farmaceuticas que los contienen. | |
GR3004448T3 (es) | ||
ITRM920155A0 (it) | Composizione farmaceutica contenente 3-2 (dimetilammino) etil-n-metil-1h-indol-5-metansolfonammide, e relativo procedimento di preparazione e trattamento con essa di mammiferi. | |
NZ229832A (en) | Condensed heterocyclic compounds, preparation and pharmaceutical compositions thereof | |
MX9206306A (es) | Peptidos, procedimiento para su produccion y composicion farmaceutica que los contiene. | |
ES2062355T3 (es) | Composicion farmaceutica que comprende loratadina, ibuprofeno y pseudoefedrina. | |
FI953442A (fi) | Gonadotropiinia sisältäviä pakastekuivattuja pallosia | |
MX9204268A (es) | Una composicion para la liberacion prolongada y controlada de substancias medicamentosas y un proceso para preparar la misma. | |
ES2018478B3 (es) | Un sistema para preparar una composicion desensibilizante dental. | |
DE69000641D1 (de) | Imipramin enthaltende arzneizubereitungen. | |
ES2052603T3 (es) | Derivados de bencimidazol, procedimiento para su produccion y composicion farmaceutica que los contienen. | |
BR0211198A (pt) | Composições farmacêuticas e seu uso | |
MX9201324A (es) | Nuevos compuestos para inhibir la secrecion acida gastrica en mamiferos, procedimiento para su preparacion y composicion farmaceutica que los contiene. | |
IT1263840B (it) | Formulazioni orali di ubidecarenone in forma di capsule | |
RU93058535A (ru) | Таблетка, содержащая гидрохлорид колестипола и способ ее получения | |
ES2062292T3 (es) | Un proceso para la preparacion del compuesto que tiene la estructura (7alfa,17alfa)-17-hidroxi-7-metil-19-nor-17-pregn-5(10)-in-3-ona. | |
MX5959E (es) | Procedimiento para la preparacion de composiciones farmaceuticas estables que contiene quelatos de oxitetraciclina,magnesio y calcio,en una solucion de 2-pirrolidona acuosa | |
ES2037682T3 (es) | Procedimiento para la preparacion de composiciones farmaceuticas empleando quitosanos metilados. | |
MX9207269A (es) | Bencimidazoles substituidos, proceso para su preparacion y composiciones farmaceuticas que los contienen. | |
DE3866789D1 (de) | Pharmazeutische zusammensetzungen. | |
DE69100334D1 (de) | Eine Etoposid-2-dimethylamino-Verbindung enthaltende gefriergetrocknete Arzneizubereitung. | |
MX9202432A (es) | Compuestos de 4,5-dihidro-1,4-benzotiazepin-3(2h)onas, procedimiento para su preparacion y composiciones farmaceuticas que los contienen. | |
MX23878A (es) | Copolimero que contiene vinil acetato, composicion que lo contiene y procedimiento para la preparacion del mismo. | |
IT1259140B (it) | Formulazioni farmaceutiche per la somministraziane orale di calcitonina |